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MaBACKGROUND Hemodynamics assessment is important for detecting and treating post-implant residual heart failure,
but its accuracy is unveriﬁed in patients with continuous-ﬂow left ventricular assist devices (CF-LVADs).
OBJECTIVES We determined whether Doppler and 2-dimensional transthoracic echocardiography reliably assess he-
modynamics in patients supported with CF-LVADs.
METHODS Simultaneous echocardiography and right heart catheterization were prospectively performed in 50
consecutive patients supported by using the HeartMate II CF-LVAD at baseline pump speeds. The ﬁrst 40 patients were
assessed to determine the accuracy of Doppler and 2-dimensional echocardiography parameters to estimate hemody-
namics and to derive a diagnostic algorithm for discrimination between mean pulmonary capillary wedge pressure #15
versus >15 mm Hg. Ten patients served as a validation cohort.
RESULTS Doppler echocardiographic and invasive measures of mean right atrial pressure (RAP) (r¼ 0.863; p < 0.0001),
systolic pulmonary arterypressure (sPAP) (r¼0.880;p<0.0001), right ventricular outﬂowtract strokevolume (r¼0.660;
p < 0.0001), and pulmonary vascular resistance (r ¼ 0.643; p ¼ 0.001) correlated signiﬁcantly. Several parameters,
including mitral ratio of the early to late ventricular ﬁlling velocities >2, RAP >10 mm Hg, sPAP >40 mm Hg, left
atrial volume index >33 ml/m2, ratio of mitral inﬂow early diastolic ﬁlling peak velocity to early diastolic mitral annular
velocity >14, and pulmonary vascular resistance >2.5 Wood units, accurately identiﬁed patients with pulmonary capillary
wedge pressure >15 mm Hg (area under the curve: 0.73 to 0.98). An algorithm integrating mitral inﬂow velocities, RAP,
sPAP, and left atrial volume indexwas90%accurate in distinguishingnormal fromelevated left ventricularﬁlling pressures.
CONCLUSIONS Doppler echocardiography accurately estimated intracardiac hemodynamics in these patients
supported with CF-LVAD. Our algorithm reliably distinguished normal from elevated left ventricular ﬁlling
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ABBR EV I A T I ON S
AND ACRONYMS
A = mitral inﬂow late diastolic
ﬁlling peak velocity
CF-LVAD = continuous-ﬂow
left ventricular assist device
E = mitral inﬂow early diastolic
ﬁlling peak velocity
e0 = early diastolic mitral
annular velocity
LAP = left atrial pressure
LAVi = left atrial volume index
LV = left ventricular
LVAD = left ventricular assist
device
NYHA = New York Heart
Association
PCWP = pulmonary capillary
wedge pressure
PVR = pulmonary vascular
resistance
RAP = right atrial pressure
rpm = revolutions per minute
RV = right ventricular
RVOT = right ventricular
outﬂow tract
sPAP = systolic pulmonary
artery pressure
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1232with left ventricular assist devices (LVADs)
for ventricular size and function, valvular
function, and potential device complications,
echocardiography remains the imaging mo-
dality of choice (3). Although echocardiogra-
phy can reliably measure right ventricular
(RV) and left ventricular (LV) hemodynamics
in patients with decompensated heart failure
(4), its utility and accuracy measured against
invasively derived hemodynamics in the
CF-LVAD population have not been fully
examined.SEE PAGE 1242Unplanned readmissions attributed to left-
sided and/or right-sided heart failure after
CF-LVAD accounts for signiﬁcant patient
morbidity (5,6). Current practice guidelines
support the use of right heart catheterization
in patients on CF-LVADs with persistent or
recurrent heart failure (7). However, invasive
testing is not always readily available and
carries intrinsic risks in this patient group
given their need for chronic anticoagulation.
We therefore performed a prospective study
to examine the application of Doppler echo-
cardiography for the hemodynamic assess-
ment of patients with CF-LVADs. In addition,we aimed to develop a practical echocardiographic
algorithm to detect elevated LV ﬁlling pressures due
to partial LV unloading in this patient population.
METHODS
PATIENT POPULATION. Between July 2009 and
December 2013, a total of 55 consecutive patients
supported with a CF-LVAD at the Houston Methodist
Hospital and with a clinical indication for invasive
hemodynamic assessment (e.g., persistent residual
heart failure, pre–heart transplant pulmonary pres-
sure assessment, or as part of a screening protocol
to evaluate for myocardial recovery) were prospec-
tively enrolled under an institutional review board–
approved protocol. Patients with a mitral valve
annuloplasty ring (n ¼ 2), signiﬁcant mitral annular
calciﬁcation (n ¼ 1), and those with suboptimal images
due to poor acoustic windows (n ¼ 2) were excluded.
All 50 patients received the HeartMate II CF-
LVAD (Thoratec Corporation, Pleasanton, California).
Simultaneous echocardiography and right heart
catheterization were performed in the catheterization
laboratory on all patients at baseline pump speed,
typically 9,000 revolutions per minute (rpm). Clinical
heart failure on CF-LVAD support was deﬁned as thepresence of shortness of breath (i.e., New York Heart
Association [NYHA] functional class III or IV symp-
toms) with an elevated pulmonary capillary wedge
pressure (PCWP) >15 mm Hg deﬁned by using the
right heart catheterization at baseline LVAD pump
speed. Right-sided heart failure was attributed to re-
sidual left-sided heart failure while on CF-LVAD
support; this assumption was made on the basis of
right heart catheterization if the mean right atrial
pressure (RAP) was >10 mm Hg in the presence of an
elevated PCWP and pulmonary hypertension.
ECHOCARDIOGRAPHIC IMAGING AND ANALYSIS.
Complete transthoracic echocardiographic studies
were performed in standard fashion in accordance
with current American Society of Echocardiography
guidelines and were reviewed by an independent
reader blinded to the invasive hemodynamic mea-
surements. From the parasternal window, LV end-
diastolic diameter, pulmonary annulus diameter,
and right ventricular outﬂow tract (RVOT) velocity
were measured per guidelines (8,9). RVOT stroke
volume was derived as the RVOT cross-sectional
area  RVOT time-velocity integral ﬂow according to
pulsed-wave Doppler (9). Right-sided cardiac output
(the sum of LVAD ﬂow and native LV outﬂow tract)
was calculated as the product of RV stroke volume
and heart rate, and indexed to body surface area to
calculate cardiac index. In addition, 2-dimensional
echocardiography and M-mode were used from the
parasternal window to record aortic valve function
per institutional guidelines in patients on CF-LVAD
support with classiﬁcation as follows: aortic valve
opening after every cardiac cycle, intermittent aortic
valve opening, or complete aortic valve closure (10).
From the apical window, left atrial volume was
measured by using the biplane method of disks from
the apical 4-chamber and apical 2-chamber views at
ventricular end-systole, then indexed to body surface
area to yield the left atrial volume index (LAVi) (8).
Pulsed-wave Doppler was used to record mitral inﬂow
for 3 to 5 cardiac cycles at the mitral valve leaﬂet tips.
Doppler signals were analyzed for mitral valve peak
early (E) and late (A) diastolic velocities, E/A ratio,
and deceleration time of mitral E velocity (11). Tissue
Doppler was applied to measure mitral annular early
(e’) velocities at the lateral and septal annulus. The
resulting annular velocities according to pulsed-wave
Doppler were recorded for 3 to 5 cardiac cycles at a
sweep speed of 100 mm/s. E/e0 ratios were computed
by using the average of the lateral and septal e0. Mitral
deceleration index was derived as mitral deceleration
time divided by peak E-wave velocity (12). Using
at least 3 cardiac cycles, the estimated left atrial
TABLE 1 Baseline Characteristics
Total
(N ¼ 40)
PCWP #15 mm Hg
(n ¼ 23)
PCWP >15 mm Hg
(n ¼ 17) p Value
Age, yrs 57  9 56  10 58  8 0.5
BMI, kg/m2 29.9  6.7 28  5 32  9 0.08
Male 32 (80) 19 (83) 14 (82) 0.9
Ischemic etiology 24 (60) 13 (57) 11 (65) 0.7
NYHA functional class 0.006
I–II 29 (73) 21 (91) 8 (47)
III–IV 11 (27) 2 (9)* 9 (53)
Race 0.05
White 18 (45) 7 (31) 11 (65)
African American 14 (35) 10 (43) 4 (23)
Hispanic 4 (10) 4 (17) 0 (0)
Other 4 (10) 2 (9) 2 (12)
Hypertension 22 (55) 12 (52) 10 (59) 0.7
Diabetes mellitus 13 (33) 8 (35) 5 (29) 0.6
Days of support 307  226 309  220 305  242 0.9
Baseline BP† 77  8 78  9 77  8 0.5
Pump speed, mean
HeartMate II 9,090  452 9,057  420 9,093  471 0.6
Selected laboratory values
BUN, mg/dl 28.4  15 27  13 30  18 0.6
Creatinine, mg/dl 1.4  0.6 1.4  0.6 1.4  0.6 0.8
Sodium, mEq/l 140  4.8 141  4 138  5 0.08
INR 1.7  0.5 1.6  0.4 1.8  0.6 0.2
Hemoglobin, mg/dl 11.3  1.4 11.5  1.0 11.1  0.9 0.7
Total bilirubin, mg/dl 0.8  0.4 0.8  0.3 0.9  0.5 0.5
AST, IU/l 52  83 35  14 77  127 0.2
ALT, IU/l 37  73 23  13 57  114 0.2
Alkaline phosphatase (IU/l) 117  49 118  56 114  39 0.8
Medications
ACEIs 18 (45) 10 (43) 8 (47) 0.9
Beta-blockers 32 (80) 18 (78) 15 (88) 0.7
Diuretic agents 25 (63) 12 (52) 13 (76) 0.2
Aldosterone antagonists 16 (40) 8 (35) 8 (47) 0.5
Readmissions‡ 0.009
No 30 (75) 21 (91) 9 (53)
Yes 10 (25) 2 (9)* 8 (47)
Indication for RHC 0.05
Shortness of breath 13 (33) 3 (13) 10 (59)
Pre-transplant evaluation 24 (60) 18 (78) 6 (35)
Recovery 3 (7) 2 (9) 1 (6)
Values are mean  SD or n (%). *One patient had exudative pleural effusions and 1 patient had anxiety/
deconditioning; both were NYHA status III/IV. †Obtained by Doppler if no pulse and/or no aortic valve opening
noted; obtained by cuff if pulse present and/or aortic valve opening noted. ‡Admissions at least once after left
ventricular assist device placement for shortness of breath evaluation.
ACEI ¼ angiotensin-converting enzyme inhibitors; ALT ¼ alanine aminotransferase; AST ¼ aspartate
aminotransferase; BMI ¼ body mass index; BP ¼ blood pressure; BUN ¼ blood urea nitrogen; INR ¼ international
normalized ratio; NYHA¼ New York Heart Association; PCWP¼ pulmonary capillary wedge pressure; RHC ¼ right
heart catheterization.
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1233pressure (LAP) on the basis of diastolic interatrial
septum position on either the apical 4-chamber or
parasternal short-axis view was assessed as follows: if
neutral atrial septal position, LAP ¼ RAP; if atrial
septal position was deviated to the right, LAP ¼ RAP þ
5; and if atrial septal position was deviated to the
left, LAP ¼ RAP  5. At least 3 cardiac cycles were
analyzed for this variable, and the effect of respira-
tion on this variable was not a protocol mandate.
Continuous-wave Doppler from multiple windows
recorded tricuspid regurgitation signals. Inferior vena
cava diameter and its collapse and hepatic venous
ﬂow were recorded in the subcostal view (13). RAP
was estimated by using the inferior vena cava diameter
and its change with respiration and hepatic venous
ﬂow recorded in the subcostal view. Systolic pulmo-
nary artery pressure (sPAP) was derived by using the
modiﬁed Bernoulli equation as sPAP ¼ 4(v)2 of peak
tricuspid regurgitation velocity inmeters per secondþ
RAP in millimeters of mercury. Pulmonary vascular
resistance (PVR) in Wood units was calculated by
using the ratio of peak tricuspid regurgitation velo-
city (meters per second) to the RVOT time-velocity
integral (centimeters)  10 þ 0.16 (14). The pulmonic
regurgitation jet was recorded per protocol; how-
ever, its feasibility was low and therefore not used
to estimate pulmonary artery diastolic pressure.
CARDIAC CATHETERIZATION. Mean RAP, systolic and
diastolic pulmonary artery pressure, mean pulmonary
pressures, and mean PCWP were measured with a
pulmonary artery catheter during right heart cathe-
terization. Fluid-ﬁlled transducers were balanced
before the study with the 0 level at the mid-axillary
line. The wedge position was veriﬁed by ﬂuoroscopy
and changes in the waveform. Cardiac output was
derived by thermodilution. Invasive measurements
were averaged over at least 5 cycles and were acquired
without knowledge of echocardiographic data. The
transpulmonary gradient was computed as mean
pulmonary artery pressure minus mean PCWP. PVR
was calculated (Wood units) as the transpulmonary
gradient divided by the calculated cardiac output.
STATISTICAL ANALYSIS. Continuous variables are
presented as mean  SD and compared by using the
Student t test; categorical variables are reported as
number and percent and were compared by using the
chi-square test. To determine the association be-
tween RV and LV hemodynamics between echocar-
diography and right heart catheterization, Pearson
correlation analysis with linear regression and
Bland-Altman plots were performed. To determine
the optimal cutoff values that distinguished patients
with normal and elevated PCWP, receiver-operatingcharacteristic curves were constructed. Values of
p < 0.05 were considered signiﬁcant. Feasibility of
the derived algorithm was calculated as the number
of patients in whom the algorithm could be applied to
determine normal versus elevated PCWP divided by
the total number of patients evaluated. Accuracy of
the algorithm was deﬁned as the number of patients
TABLE 2 Echocardiographic and Hemodynamic Characteristics
Total
(N ¼ 40)
PCWP
#15 mm Hg
(n ¼ 23)
PCWP
>15 mm Hg
(n ¼ 17) p Value
Echocardiography
LVEDd, cm 5.3  1.0 5.1  1.0 5.6  0.9 0.1
FS, % 16.0  8.7 17.7  10.0 14.1  6.8 0.2
EF, % 25.8  12.6 27  13 24  11 0.5
LAVi, ml/m2 33.1  15.9 26.9  10.0 40.5  18.5 0.009
E, cm/s 86.2  32.5 78.3  35.0 95.6  27.4 0.1
DT, ms 184.5  59.5 194  65 175.3  54 0.4
A, cm/s 61.1  33.3 69.0  19.9 50.7  24.1 0.03
E/A 1.7  1.2 1.2  0.7 2.4  1.3 0.003
e’ lateral, cm/s 7.6  2.9 8.0  3.2 7.1  2.4 0.3
e’ septal, cm/s 5.5  2.1 5.8  2.2 5.2  2.0 0.4
e’ average, cm/s 6.5  2.2 6.8  2.5 6.2  1.8 0.4
E/e’ 14.6  7.1 12.7  7.2 16.9  6.5 0.08
MDI, DT/peak e 2.5  1.6 2.8  1.4 2.2  1.7 0.3
Atrial septal position 0.5
Neutral 21 (53) 11 (48) 10 (59)
Atrial septal position
to right
2 (5) 0 (0) 2 (12)
Atrial septal position
to left
7 (18) 6 (26) 1 (6)
Estimated left atrial
pressure*
8.7  5.5 5.8  3.5 14.5  3.9 0.0001
RVOT TVI, cm 12.0  3.5 12.2  3.4 11.7  3.6 0.7
CO, L/min 4.9  1.6 4.6  1.0 5.3  2.2 0.2
CI, L/min/m2 2.1  0.7 2.1  0.6 2.1  0.8 0.9
AV opening time, ms 106.2  94.8 131.8  95.7 61.5  79.4 0.09
RAP, mm Hg 9.8  5.2 6.6  2.9 14.9  3.7 <0.0001
sPAP, mm Hg 37.4  10.0 30.5  5.0 46.4  7.2 <0.0001
PVR, WU 2.7  1.2 2.2  0.5 2.9  1.2 0.04
RV size, qualitative 0.07
Normal 28 (70) 19 (83) 9 (53)
Mild 6 (15) 2 (9) 4 (23)
Mild–moderate 1 (2) 0 (0) 1 (6)
Moderate 3 (8) 1 (4) 2 (12)
Moderate–severe 1 (2) 1 (4) 0 (0)
Severe 1 (2) 0 (0) 1 (6)
RV function, qualitative 0.5
Normal 19 (47) 12 (52) 7 (41)
Mild 7 (18) 4 (17) 3 (18)
Mild–moderate 3 (8) 3 (13) 0 (0)
Moderate 7 (18) 2 (9) 5 (29)
Moderate–severe 3 (8) 2 (9) 1 (6)
Severe 1 (2) 0 (0) 1 (6)
AV function
Open with every cardiac
cycle
20 (50) 13 (57) 7 (41) 0.5
Intermittent 12 (30) 6 (26) 6 (35) 0.9
Closed 8 (20) 4 (17) 4 (24) 0.5
AI severity qualitative 0.5
None or trace 26 (65) 16 (70) 10 (59)
Mild 9 (23) 7 (30) 2 (12)
Mild–moderate 4 (10) 0 (0) 4 (23)
Moderate 1 (2) 0 (0) 1 (6)
Moderate-severe 0 (0) 0 (0) 0 (0)
Severe 0 (0) 0 (0) 0 (0)
Continued on the next page
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1234with correctly predicted PCWP (normal or elevated)
divided by the total number of patients with a
feasible algorithm assessment.
RESULTS
Among 40 patients comprising the initial derivation
study population, the mean age was 57  9 years, 32
were male (80%), and 24 had ischemic etiology of
heart failure (60%). Table 1 summarizes a compari-
son of baseline characteristics of patients who had
normal (n ¼ 23) versus elevated (n ¼ 17) PCWP at
baseline pump speed support. There were no sig-
niﬁcant differences between groups, including var-
iables that may affect clinical heart failure in
patients on CF-LVADs, such as the degree of un-
derlying LV unloading inﬂuenced by the baseline
pump speed setting, duration of LVAD support,
systemic hypertension, and medication utilization.
Nine (53%) of 17 patients with resting PCWP >15
mm Hg were symptomatic (NYHA functional class
III or IV), with 8 (89%) of these patients readmitted
at least once after LVAD placement for clinical heart
failure due to partial LV unloading while on CF-
LVAD support. In addition, 9 (53%) of the 17 pa-
tients with PCWP >15 mm Hg had at least mild or
greater mitral regurgitation severity compared with
only 22% of the patients with PCWP #15 mm Hg,
which is also reﬂective of partial LV unloading.
The invasive hemodynamic proﬁle of those pa-
tients with PCWP >15 mm Hg consisted of moderately
elevated left-sided ﬁlling pressure (mean PCWP 21.2 
5.4 mm Hg) with secondary pulmonary hypertension
(mean pulmonary artery pressure 34.0  6.8 mm Hg).
On the basis of our catheter-derived parameters, an
elevated RAP (mean RAP 14.8  5.7 mm Hg) was noted
at a baseline mean pump speed of 9,093  471 rpm in
19 of 40 patients. Fourteen (74%) of these 19 patients
with elevated RAPs had a concomitant elevated sPAP
>40 mm Hg, and 16 (84%) of these 19 patients had an
underlying PCWP >15 mm Hg. These results highlight
that left-sided heart failure attributed to partial LV
unloading while on a CF-LVAD is the main cause of
right-sided heart failure in this patient population.
The vast majority of patients (76%) with PCWP
>15 mm Hg had normal or only mildly reduced qual-
itative RV systolic function and had normal RV
outﬂow tract cardiac output. As noted in Table 2, the
minority of these patients (18%) had tricuspid regur-
gitation of moderate or greater severity.
FEASIBILITY OF ECHOCARDIOGRAPHIC MEASUREMENTS.
Of 40 patients, right-sided indices, including RAP
and RV cardiac output and index, were calculable
in 80.6% and 92.5% of the study population,
TABLE 2 Continued
Total
(N ¼ 40)
PCWP
#15 mm Hg
(n ¼ 23)
PCWP
>15 mm Hg
(n ¼ 17) p Value
MR severity, qualitative† 0.05
None or trace 26 (65) 18 (78) 8 (47)
Mild 9 (23) 3 (13) 6 (35)
Mild-moderate 3 (8) 2 (9) 1 (6)
Moderate 1 (2) 0 (0) 1 (6)
Moderate–severe 1 (2) 0 (0) 1 (6)
Severe 0 (0) 0 (0) 0 (0)
TR severity, qualitative† 0.2
None or trace 20 (50) 13 (57) 7 (41)
Mild 14 (35) 9 (39) 5 (29)
Mild–moderate 3 (8) 1 (4) 2 (12)
Moderate 2 (5) 0 (0) 2 (12)
Moderate–severe 1 (2) 0 (0) 1 (6)
Severe 0 (0) 0 (0) 0 (0)
Inﬂow cannula
malposition, n
3 (8) 2 (7) 1 (6) 0.8
Invasive hemodynamics
mRAP, mm Hg 9.9  6.1 6.5  3.4 14.8  5.7 <0.0001
sPAP, mm Hg 39.5  14.4 30.3  7.0 52.7  11.9 <0.0001
dPAP, mm Hg 16.3  7.7 11.1  3.7 23.9  5.0 <0.0001
mPAP, mm Hg 24.3  9.7 17.7  3.3 34.0  6.8 <0.0001
TPG, mm Hg 10.3  5.8 8.6  3.6 11.8  7.3 0.06
PVR, WU 2.0  0.8 1.8  0.9 2.2  0.8 0.08
PCWP, mm Hg 13.8  7.9 8.4  4.0 21.2  5.4 <0.0001
CO, l/min 5.2  0.9 5.1  0.8 5.3  1.0 0.6
CI, l/min/m2 2.5  0.4 2.6  0.4 2.4  0.4 0.2
Values are mean  SD or n (%). *Calculated as follows: if neutral atrial septal position, LAP was noted to be equal
to RAP; if atrial septal position to the right, LAP is noted as RAP þ 5; and if atrial septal position to the left, LAP
noted as RAP – 5. †Quantiﬁed according to American Society of Echocardiography guidelines.
A ¼ mitral inﬂow late diastolic ﬁlling peak velocity; AI ¼ aortic insufﬁciency; AV ¼ aortic valve; CI ¼ cardiac
index; CO ¼ cardiac output; dPAP ¼ diastolic pulmonary artery pressure; DT ¼ mitral valve deceleration time;
E ¼ mitral inﬂow early diastolic ﬁlling peak velocity; e0 ¼ early diastolic mitral annular velocity; EF ¼ ejection
fraction; FS ¼ fractional shortening; LAVi ¼ left atrial volume index; LVEDd ¼ left ventricular end diastolic
dimension; MDI¼mitral deceleration index; mPAP¼mean pulmonary artery pressure; MR¼mitral regurgitation;
mRAP ¼ mean right atrial pressure; PVR ¼ pulmonary vascular resistance in Wood units (WU); RAP ¼ right atrial
pressure; RV¼ right ventricular; RVOT TVI¼ right ventricular outﬂow tract time velocity integral; sPAP¼ systolic
pulmonary artery pressure; TPG ¼ transpulmonary gradient; TR ¼ tricuspid regurgitation; other abbreviation as
in Table 1.
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1235respectively (Table 3). Distinct early and late mitral
inﬂow velocities (E and A) were measurable in 30
(75%) of the patients, and 10 (25%) of the patients had
fused or inadequate mitral inﬂow velocities due to
tachycardia and/or suboptimal imaging, respectively.
Assessment of tissue Doppler velocities was highly
feasible for lateral (92.5%) and septal (87.5%) mitral
annular velocities. Tricuspid regurgitation velocities
were satisfactorily acquired in 32 patients (80%).
Representative echocardiography measurements are
shown in Figures 1 and 2.
ESTIMATION OF RIGHT-SIDED HEMODYNAMICS. Non-
invasive and invasive measurements of mean right
atrial pressure and sPAP were strongly correlated
(r ¼ 0.863 and 0.880, respectively; p < 0.0001)
(Figure 3). Echocardiographic estimates of RV outﬂow
tract stroke volume and PVR also had a signiﬁcant
correlation (r ¼ 0.660 and 0.643; p < 0.0001 and
0.001, respectively) (Figure 4). Excluding patients
with moderate to severe mitral regurgitation and
moderate to severe tricuspid regurgitation, echocar-
diographic estimates of right-sided or systemic car-
diac output while on CF-LVAD support had a
signiﬁcant correlation (r ¼ 0.516; p ¼ 0.002).
ECHOCARDIOGRAPHIC PARAMETERS AND MEAN
PCWP CORRELATION. Several echocardiographic
parameters differed signiﬁcantly between patients
with PCWP #15 mm Hg and those with PCWP
>15 mm Hg, including: LAVi; mitral A velocity; E/A
ratio; RAP; estimated LAP on the basis of the position
of the interatrial septum; sPAP; and PVR (Table 2). As
demonstrated in Table 3, several of the 18 examined
Doppler and 2-dimensional echocardiographic para-
meters correlated signiﬁcantly with mean PCWP:
mean RAP (r ¼ 0.825; p < 0.0001); sPAP (r ¼ 0.795;
p<0.0001); LAVi (r¼0.488; p¼0.003); PVR (r¼0.451;
p¼ 0.018); mitral A velocity (r¼ –0.414; p¼ 0.023); E/A
ratio (r ¼ 0.481; p ¼ 0.007); and estimated LAP on the
basis of the interatrial position and echocardiography-
derived RAP (r ¼ 0.657; p ¼ 0.003). Similarly, several
variables showed good accuracy in identifying
patients with PCWP >15 mm Hg by using cutoff values
established by receiver-operating characteristic
curves (Table 4).
ECHOCARDIOGRAPHIC ALGORITHM TO DISTINGUISH
BETWEEN NORMAL AND ELEVATED PCWP. On the basis
of good accuracy in identifying patients with PCWP
>15 mm Hg, Doppler parameters that had feasibility
of at least 75%, including E/A ratio, RAP or sPAP,
LAVi, and E/e0, were selected with their respective
cutoff values to create an algorithm for estimation
of ﬁlling pressures. In keeping with an establishedalgorithm to predict elevated left-sided ﬁlling pres-
sures in heart failure patients with depressed LVEF,
the mitral E/A ratio was selected as the focal point
(Figure 5) (11), followed by 3 candidate Doppler pa-
rameters: RAP or sPAP, LAVi, and E/e0. Patients with
E/A #1 and with any 1 other parameter (e.g.,
RAP #10 mm Hg or sPAP #40 mm Hg and/or LAVi #33
ml/m2 and/or E/e0 #14) were examined to detect
PCWP #15 mm Hg. In contrast, patients with E/A >2
with any 1 parameter such as RAP >10 mm Hg or sPAP
>40 mm Hg and/or LAVi >33 ml/m2 and/or E/e0 >14
were examined to detect elevated PCWP (>15 mm Hg).
To distinguish between normal and elevated PCWP
for patients with E/A ratios >1 to #2 (indeterminate
group), 2 additional concordant ﬁndings from the
3 candidate categories were examined.
TABLE 3 Feasibility and Correlation of
Echocardiographic Parameters With Mean PCWP (N ¼ 40)
No. (%) of Patients With
Satisfactory Signal r p Value
LVEF, % 40 (100) –0.130 0.422
LVEDd, cm 40 (100) 0.281 0.083
CO, L/min 37 (92.5) 0.076 0.656
CI, L/min/m2 37 (92.5) –0.111 0.083
RAP, mm Hg 25 (81)* 0.825 <0.0001
sPAP, mm Hg 23 (74)* 0.795 <0.0001
LAVi, ml/m2 36 (90) 0.488 0.003
PVR, WU 27 (67.5) 0.451 0.018
DT, ms 32 (80) –0.309 0.085
E, cm/s 35 (95) 0.309 0.051
A, cm/s 30 (75) –0.414 0.023
E/A 30 (75) 0.481 0.007
e0 septal, cm/s 35 (95) –0.238 0.168
e0 lateral, cm/s 37 (92.5) –0.124 0.466
e0 average, cm/s 35 (95) –0.144 0.417
E/e0 33 (82.5) 0.347 0.057
MDI, DT/peak E 32 (80) –0.329 0.067
Estimated LAP† 20 (65) 0.657 0.003
*N ¼ 31 for RAP/sPAP (subcostal imaging for inferior vena cava and hepatic veins
not attempted or performed in 9 patients who were supine and with a sterile cover
before echocardiographic acquisition). †Calculated as: if neutral atrial septal
position, LAPwas noted to be equal to RAP; if atrial septal position to the right, LAP
is noted as RAP þ 5; and if atrial septal position to the left, LAP noted as RAP – 5.
LVEDd ¼ left ventricular end-diastolic diameter; LVEF ¼ left ventricular ejection
fraction; other abbreviations as in Table 2.
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1236The algorithm was feasible in 29 (73%) of the
40 patients. Of the 11 patients for whom the algorithm
could not be applied, 4 were in the indeterminate
group (E/A ratio >1 to #2), and 7 had indistinct E and
A waves. These patients either lacked echocardio-
graphic parameters from the 3 candidate categories or
had discordant candidate parameters to provide aniography Assessment in a Patient With Normal PCWP
HeartMate II continuous-ﬂow left ventricular assist device (Thoratec Corporat
estimated pulmonary capillary wedge pressure (PCWP) <15 mm Hg (actual PC
te for illustration purposes, lateral e0 was used for the E/e0 calculation; in the
ted systolic pulmonary artery pressure (sPAP) of 28 mm Hg using an echocar
ﬁlling peak velocity; A ¼ mitral inﬂow late diastolic ﬁlling peak velocity; e0assessment (normal or elevated PCWP). Overall, the
accuracy of the algorithm to distinguish normal from
elevated PCWP in the derivation cohort with available
candidate echocardiographic parameters (RAP or
SPAP, LAVi, and E/e0) was 90% (26 of the 29 patients
were appropriately categorized as having normal or
elevated PCWP) (Figure 6).
Characteristics of the validation cohort (n ¼ 10)
are shown in Table 5. As shown, this patient popula-
tion was similar to the derivation cohort. The algo-
rithm (Figure 5) could be applied to 9 of the 10
patients (90% feasibility) with an overall accuracy of
89% to correctly distinguish normal from underlying
elevated PCWP. It was not possible to apply the
algorithm to 1 patient in the validation. This patient
had an E/A >1 and #2 (indeterminate group), an RAP
and SPAP that were unavailable due to feasibility, and
left atrial volume index and E/e0 that were discordant
(48 ml/m2 with an E/e0 of 11.8, respectively).
DISCUSSION
The effect of continuous ﬂow (LV to apical inﬂow
cannula) on mitral inﬂow parameters and, in turn, the
association between these echocardiographic param-
eters and LV ﬁlling pressure are incompletely un-
derstood. This is the ﬁrst comprehensive study
designed to validate the reliability of noninvasive
estimation of intracardiac hemodynamics in patients
on CF-LVAD support by using simultaneous echo-
cardiography and right heart catheterization.
Very few studies have examined the correlation
among echocardiographic parameters, invasively de-
ﬁned hemodynamics, and adverse outcomes (i.e.,
clinical heart failure) while on CF-LVAD support.
Andersen et al. (15) demonstrated in 12 patients onion, Pleasanton, California) at a pump speed of 9,000 revolutions per
WP 9 mm Hg) on the basis of a calculated E/A ratio of 0.62 (<1.0) and
study, E/e0 was derived by averaging the lateral and septal e0 values,
diography-derived right atrial pressure (RAP) of 5 mm Hg. E ¼ mitral
¼ early diastolic mitral annular velocity.
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FIGURE 3 Correlation Plots of RAP and sPAP
The correlation between (A) RAP and (C) sPAP measured by Doppler and by right
heart catheterization is shown (left panels). The Bland-Altman plot is also illustrated
(right panels [B and D]). Cath ¼ catheterization; Rt ¼ right.
FIGURE 2 Echocardiography Assessment in a Patient With Elevated PCWP
Different patient example on a HeartMate II continuous-ﬂow left ventricular assist device (Thoratec Corporation, Pleasanton, California) at a similar pump speed of
9,000 rpm with an underlying elevated PCWP (actual PCWP 20 mm Hg) on the basis of a calculated E/A ratio of 2.0 and an E/e0ratio >14 along with an estimated sPAP of
48 mm Hg by using an echocardiography-derived RAP of 15 mm Hg. Other abbreviations as in Figure 1.
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1237HeartMate II support that, at rest, tissue Dop-
pler–derived mitral annular peak systolic velocity
positively correlated (r ¼ 0.41) with cardiac output
by using the thermodilution method. These in-
vestigators also showed a positive correlation
between the E/e0 ratio with diastolic PAP at rest
(r ¼ 0.39). In contrast to the standard echocardio-
graphic surrogates reﬂective of elevated left-sided
ﬁlling in patients with heart failure, Topilsky et al.
(12) reported that novel parameters, including mitral
deceleration index and LAP estimated on the basis
of diastolic interatrial septum position, correlated
with PCWP among patients with CF-LVADs (n ¼ 8;
r ¼ –0.72 and 0.74 for mitral deceleration index and
estimated LAP, respectively). However, these studies
were limited by sample size and the paucity of echo-
cardiographic parameters examined (12,15). Two other
reports demonstrated that in ambulatory patients on
CF-LVADs (i.e., 1 to 3 months after implantation),
parameters including signiﬁcant prolongation of the
mitral deceleration time, decrease in left atrial size,
and decrease in E velocity and the E/e0 ratio were
echocardiographic surrogates of decreased LV ﬁlling
pressure (16,17). These studies did not, however,
provide echocardiographic cutoff values that may be
important for detecting elevated PCWP while on
CF-LVAD support.
Our results, derived from the largest series
of patients reported on to date, demonstrate that
several echocardiographic parameters (including
RAP, an established hemodynamic marker of elevated
left-sided pressure in heart failure patients) strongly
correlate with invasive hemodynamics. On the basis
of our catheter-derived parameters, an elevated RAP
in this patient population was predominantly sec-
ondary to left-sided heart failure attributed to partialLV unloading (persistently elevated PCWP) while on a
CF-LVAD. LAP estimated on the basis of interatrial
septum position determined by echocardiography
and echocardiography-derived RAP (as originally
proposed by Topilsky et al. [12]) was also among the
parameters that correlated with PCWP.
More important than establishing these correla-
tions, we provide potentially important cutoff values
to detect elevated PCWP while on CF-LVAD support,
including an RAP >10 mm Hg, sPAP >40 mm Hg,
and LAVi >33 ml/m2, parameters associated with area
TABLE 4 Accuracy o
Cut
RAP, mm Hg >1
sPAP, mm Hg >4
LAVi, ml/m2 >3
PVR, WU >2
E/A >
E/e0 >1
DT, ms <15
E, cm/s >7
A, cm/s <6
MDI, DT/peak E <2
Values are from the deriva
AUC ¼ area under the cu
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FIGURE 4 Correlation Plots of SV and PVR
The correlation between (A) stroke volume (SV) and (C) pulmonary vascular resistance
(PVR) measured by echocardiography and by right heart catheterization is shown
(left panels). The Bland-Altman plot is also illustrated (right panels [B and D]).
WU ¼ Wood units; other abbreviations as in Figure 3.
Mitral E/A
E/A ≤1
+ any 1 parameter
E/A >2
+ any 1 parameter
E/A >1, ≤2*
+ 2 of 3 parameters
(a) RAP >10 or
sPAP >40 mm Hg
(b) LAVi >33 mL/m2
(a) RAP ≤10 or
sPAP ≤40 mm Hg
(b) LAVi ≤33 mL/m2
(c) E/e’ ≤14 (c) E/e’ >14
PCWP ≤15 PCWP >15
FIGURE 5 Echocardiography Algorithm
Proposed algorithm for estimation of left ventricular (LV) ﬁlling
pressures in LVAD patients. *In the presence of fused or indistinct
E and A signals, 2 of 3 parameters must be met and concordant.
LAVi ¼ left atrial volume index; other abbreviations as in
Figure 1.
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1238under the curves of 0.95, 0.98, and 0.78, respectively.
However, accuracy on the basis of sensitivity and
speciﬁcity ranges for detecting partial unloading
(PCWP >15 mm Hg) on CF-LVADs was only modest for
individual parameters (38% to 81% and 44% to
100%, respectively). The strength of our proposed
algorithm is 2-fold: 1) it is practical in that it includes
several standard and readily available parameters
that mirror proposed algorithms on the basis of mitral
valve inﬂow indices used to evaluate left-sided ﬁlling
pressures in heart failure (non-LVAD) patients; and 2)f Echocardiographic Parameters to Predict PCWP >15 mm Hg
off Sensitivity (%) Speciﬁcity (%)
AUC
(95% Conﬁdence
Interval) p Value
0 78 93 0.95 (0.88–1.0) 0.0002
0 74 100 0.98 (0.93–1.0) 0.0001
3 70 84 0.78 (0.63–0.94) 0.003
.5 67 75 0.73 (0.54–0.92) 0.04
2 60 89 0.79 (0.62–0.97) 0.003
4 79 62 0.73 (0.54–0.90) 0.03
0 38 81 0.61 (0.41–0.81) 0.27
5 81 58 0.71 (0.53–0.90) 0.03
0 61 71 0.73 (0.54–0.92) 0.03
.5 81 44 0.71 (0.53–0.89) 0.03
tion cohort (N ¼ 40).
rve; other abbreviations as in Table 2.it has good potential accuracy (w90%) in detecting
residual left-sided heart failure. In an increasing
destination therapy patient population on CF-LVAD
support, in whom comorbidities such as chronic
obstructive pulmonary disease and obesity are not
uncommon and can contribute to heart failure–like
symptoms, this ﬁnding has potentially signiﬁcant
clinical diagnostic and management implications. The
physical examination is commonly challenging in
these types of patients. In such a scenario, we ﬁnd the
provided echocardiography algorithm very useful for
diagnosing complete (normal PCWP) or partial
(elevated PCWP) LV unloading while on CF-LVAD
support. For those patients with NYHA functional
class III or greater dyspnea and echocardiographic
surrogates of an underlying elevated PCWP, consid-
eration is given to initiate or augment diuretic agents,
more aggressively screen for occult hypertension, and
to increase the level of pump speed support to decrease
PCWP and minimize congestion. In our experience,
persistent symptoms of shortness of breath (NYHA
functional class III/IV) were associated with underly-
ing elevated PCWP in the majority of these patients.
Our derived echocardiography algorithm is most
helpful clinically as a complement to the history and
physical examination and to conﬁrm underlying par-
tial LV unloading to guide subsequent treatment
(Central Illustration). Although the provided algorithm
can be successfully applied in the majority of pa-
tients, for those with either an uninterpretable echo-
cardiogram due to poor acoustic windows or with
equivocal results, we still use invasive right heart
catheterization to delineate if persistent dyspnea
and/or fatigue are attributed to smoldering left-
and/or right-sided heart failure.
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FIGURE 6 Performance Characteristics of the
Proposed Algorithm
The calculated area under the curve for the algorithm to distin-
guish elevated from normal ﬁlling pressures in the combined
study cohorts (derivation and validation) was 0.89 (conﬁdence
interval: 0.77 to 1.0), with a sensitivity of 88%, a speciﬁcity of
91%, and p < 0.0001.
CENTRAL ILLUSTRATION Algorithm for CF-LVAD Persistent HF Symptoms
Treatment algorithm for persistent heart failure (HF) symptoms for patients on
continuous-ﬂow left ventricular assist devices (CF-LVADs). *In the presence of fused or
indistinct E and A signals, 1 of 3 parameters must be met and concordant. **Other echo
ﬁndings are non-diagnostic (e.g., no pericardial effusion).
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1239To the best of our knowledge, the present study is
the ﬁrst to report the signiﬁcant correlation between
echocardiography and invasively derived PVR while
on CF-LVAD support. Echocardiography-derived PVR
had a modest correlation with mean PCWP (r ¼ 0.45;
p ¼ 0.018) and was somewhat accurate in predicting
PCWP >15 mm Hg (area under the curve: 0.73;
p ¼ 0.04). However, as with other echocardiographic
parameters, echocardiography-derived PVR in isola-
tion cannot reliably distinguish patients with a
normal PCWP versus elevated PCWP. Our ﬁndings do
support the observation that elevated PVR derived by
using echocardiography is a marker of partial LV
unloading and residual heart failure as reported by
others and is a potential marker of worse clinical
status while on CF-LVADs (17). Topilsky et al. (12)
demonstrated that echocardiographic surrogates of
elevated left-sided ﬁlling pressure, mitral decelera-
tion index, and LAP estimated on the basis of the
interatrial septum position were both associated with
adverse 90-day outcomes, deﬁned as persistent
NYHA functional class III or IV symptoms, heart fail-
ure readmission, or death. In our study, LAP esti-
mated on the basis of interatrial septum position
correlated with mean PCWP and was signiﬁcantly
different between patients with PCWP #15 mm Hg
versus >15 mm Hg. However, because this parameter
was predominantly driven by echocardiography-
derived RAP, and RAP was associated with greater
signiﬁcance in its correlation with mean PCWPcompared with estimated LAP by using the interatrial
septum position, it is not a parameter in our proposed
algorithm. In addition, this parameter had lower
feasibility versus other parameters. Also, in contrast
to the study of Topilsky et al. (12), the calculated
mitral deceleration index in our cohort of patients did
not correlate with mean PCWP. In our patients, a
mitral deceleration index cutoff value <2.5 was sen-
sitive (81%); however, it lacked speciﬁcity (44%) to
accurately predict PCWP compared with other stan-
dard echocardiographic parameters.
TABLE 5 Characteristics of Validation Cohort
Total
(N ¼ 10)
PCWP #15 mm Hg
(n ¼ 6)
PCWP >15 mm Hg
(n ¼ 4) p Value
Age, yrs 51  14 45  10 59  15 0.1
Male, % 6 (60) 4 (67) 2 (50) 0.9
White race, % 7 (70) 4 (67) 3 (75) 0.5
Ischemic etiology, % 3 (30) 1 (17) 2 (50) 0.1
Hypertension, % 5 (50) 3 (50) 2 (50) 0.5
Diabetes mellitus, % 4 (40) 2 (33) 2 (50) 0.5
Baseline pump speed, rpm 9,040  184 8,967  151 9,150  190 0.1
Heart rate, beats/min 73  13 76  13 70  11 0.4
Echocardiography
EF, % 20.5  6.1 20.1  6.7 21.3  6 0.7
LVEDd, cm 5.5  1.2 5.1  1.2 6.3  1 0.2
LAVi, ml/m2 36  20.9 22.4  8.3 56.4  16.4 0.009
DT, ms 239.6  124.5 291.6  140 161.4  17.3 0.1
E, cm/s 90.6  20.1 77.1  17 110.9  22.1 0.01
A, cm/s 58.7  25.3 69.3  26.1 42.9  14.8 0.1
E/A 2.2  1.2 1.7  1 2.8  1.2 0.2
e0 septal, cm/s 6.9  3.4 8.3  3.5 4.9  2.4 0.2
e0 lateral, cm/s 9.9  3.4 10.5  4.0 8.5  1.3 0.5
e0 average, cm/s 8.2  3.3 9.4  3.7 6.4  1.6 0.06
E/e0 12.7  6.1 9.0  3.1 18.1  5.4 0.009
RAP, mm Hg 10  5.6 5.0  0.1 15  0.1 <0.001
sPAP, mm Hg 34.8  11 25.6  3.4 44  4 <0.001
Invasive hemodynamics
RAP, mm Hg 9  5.7 5.5  3.7 13  5.4 0.03
sPAP, mm Hg 36  13.4 26.3  6.9 50  3.6 0.002
dPAP, mm Hg 14  7.4 9  5 20.3  4.6 0.006
mPAP, mm Hg 22  8.6 16  5.4 30.3  3.1 0.009
PCWP, mm Hg 12  5.6 8.2  1.8 18.3  2.4 0.009
CO, L/min 5  0.9 5.2  0.7 5.2  1.3 0.9
CI, L/min/m2 3  0.4 2.7  0.4 2.5  0.4 0.3
Values are mean  SD or n (%).
rpm ¼ revolutions per minute; other abbreviations as in Tables 1 and 2.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE:
Doppler velocity measurements provide accurate
estimation of intracardiac pressures in patients sup-
ported with the HeartMate II CF-LVAD.
COMPETENCY IN PATIENT CARE: Doppler-
echocardiography can provide an objective estimate
of pulmonary capillary wedge pressure and right heart
pressures to guide management of a patient with
persistent heart failure symptoms despite CF-LVAD
support.
TRANSLATIONAL OUTLOOK: Further studies are
needed to understand the limitations of Doppler-
echocardiography in patients with heart failure
receiving CF-LVAD support and to deﬁne the speciﬁc
therapeutic implications of these noninvasive hemo-
dynamic assessments.
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1240Our results demonstrate that Doppler and
2-dimensional echocardiography can be readily
applied to the majority of patients implanted with a
CF-LVAD. A comprehensive right-sided hemody-
namic proﬁle including RAP, RV stroke volume, PVR,
and sPAP was feasible in the majority of our patients.
In addition, we were able to apply the proposed
algorithm to distinguish normal and elevated PCWP,
which incorporates left atrial volume index and E/e0
with good feasibility and accuracy.
STUDY LIMITATIONS. Our study limitations included
the fact that this was a single-center experience, was
of limited sample size for those with persistently
elevated PCWP on CF-LVAD support, and was a rela-
tively small validation cohort; this design resulted in
larger conﬁdence intervals despite optimal correla-
tion coefﬁcients and suggests that external validation
of our results in larger cohorts is needed. Also,
several key echocardiographic variables could not bemeasured in all patients. Our study examined only 1
type of CF-LVAD on the basis of axial ﬂow physiology,
and our ﬁndings may therefore not be applicable to
patients on other types of CF-LVADs. Although our
proposed echocardiographic algorithm to distinguish
normal versus elevated PCWP was feasible in the
majority of patients (76%), it may not be possible to
apply in some patients.
CONCLUSIONS
Doppler echocardiographic estimation of left-
sided and right-sided hemodynamics in patients
supported with CF-LVADs remains accurate. Our
proposed diagnostic algorithm integrating simple and
standard echocardiographic parameters (i.e., mitral
E/A ratio, RAP, sPAP, LAVi, E/e0) can reliably distin-
guish between normal and elevated LV ﬁlling pres-
sures on baseline levels of LVAD support and can be
used to detect partial LV unloading. Our ﬁndings
merit validation in a larger, multicenter study. Future
research should focus on whether these echocardio-
graphic parameters or a combination of parameters
are sensitive to ﬁlling pressure changes.
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